FDA Drug information
Pristiq Extended-Release
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- Pristiq Extended-Release DESVENLAFAXINE SUCCINATE 100 mg/1 Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- Pristiq Extended-Release DESVENLAFAXINE SUCCINATE 25 mg/1 Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- Pristiq Extended-Release DESVENLAFAXINE SUCCINATE 50 mg/1 Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.